1. Home
  2. MTN vs RLAY Comparison

MTN vs RLAY Comparison

Compare MTN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vail Resorts Inc.

MTN

Vail Resorts Inc.

N/A

Current Price

$155.13

Market Cap

5.2B

ML Signal

N/A

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

N/A

Current Price

$8.09

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTN
RLAY
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
1.3B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MTN
RLAY
Price
$155.13
$8.09
Analyst Decision
Hold
Strong Buy
Analyst Count
10
7
Target Price
$176.50
$16.00
AVG Volume (30 Days)
977.1K
2.1M
Earning Date
12-10-2025
11-06-2025
Dividend Yield
5.62%
N/A
EPS Growth
17.26
N/A
EPS
7.24
N/A
Revenue
$2,975,101,000.00
$8,355,000.00
Revenue This Year
$2.69
$20.47
Revenue Next Year
$3.45
N/A
P/E Ratio
$21.84
N/A
Revenue Growth
3.06
N/A
52 Week Low
$129.85
$1.78
52 Week High
$194.47
$9.04

Technical Indicators

Market Signals
Indicator
MTN
RLAY
Relative Strength Index (RSI) 59.76 58.26
Support Level $140.00 $7.42
Resistance Level $163.34 $9.04
Average True Range (ATR) 4.66 0.47
MACD 2.21 0.02
Stochastic Oscillator 68.93 42.54

Price Performance

Historical Comparison
MTN
RLAY

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: